Home LiteratureArticle Details
PMID: 2297817 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia.

Circulation research ·Vol. 66 ·No. 2 ·1990-02-00 ·Pages 546-53

Lopaschuk GD, Spafford MA, Davies NJ, Wall SR

Abstract

Alterations in energy substrate utilization during reperfusion of ischemic hearts can influence the functional recovery of the myocardium. Energy substrate preference by the reperfused myocardium, however, has received limited attention. Therefore, we measured oxidation rates of glucose and palmitate during reperfusion of ischemic hearts. Isolated working rat hearts were perfused with 1.2 mM palmitate and 11 mM [14C]glucose, 1.2 mM [14C]palmitate and 11 mM glucose, or 11 mM [14C]glucose alone, at an 11.5 mm Hg preload and 80 mm Hg afterload. Hearts were subjected to 60-minute aerobic perfusion or 25-minute global ischemia followed by 60-minute aerobic reperfusion. Steady-state oxidative rates of glucose or palmitate were determined by measuring 14CO2 production. In hearts perfused with glucose alone, oxidative rates during reperfusion were not significantly different than nonischemic hearts (1,008 +/- 335 vs. 1,372 +/- 117 nmol [14C]glucose oxidized/min/g dry wt, respectively). In the presence of palmitate, glucose oxidation was markedly reduced in reperfused and nonischemic hearts (81 +/- 11 and 101 +/- 15 nmol [14C]glucose oxidized/min/g dry wt, respectively). Palmitate oxidation rates were not significantly different in reperfused compared with nonischemic hearts (369 +/- 55 and 455 +/- 50 nmol [14C]palmitate oxidized/min/g dry wt, respectively). [14C]Palmitate was incorporated into myocardial triglycerides to a greater extent in reperfused ischemic hearts than in nonischemic hearts (26.0 and 13.8 mumol/g dry wt, respectively). Under the perfusion conditions used, palmitate provided over 90% of the ATP produced from exogenous substrates. Addition of the carnitine palmitoyltransferase I inhibitor, ethyl 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (Etomoxir, 10(-6) M), during reperfusion stimulated glucose oxidation and improved mechanical recovery of ischemic hearts.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Animals Coronary Disease/metabolism,physiopathology Fatty Acids/metabolism Glucose/metabolism Heart/physiopathology In Vitro Techniques Male Myocardial Reperfusion Myocardium/metabolism Oxidation-Reduction Palmitates/metabolism Palmitic Acids/metabolism Rats Rats, Inbred Strains Triglycerides/metabolism
Chemicals
Fatty Acids Palmitates Palmitic Acids Triglycerides Glucose
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lopaschuk G D
Department of Pediatrics, University of Alberta, Edmonton, Canada.
Spafford M A
Davies N J
Wall S R
Article Info
Journal
Circulation research
Abbr.
Circ Res
ISSN
0009-7330
Published
1990-02-00
Pages
546-53
Language
English
Region
United States
NLM ID
0047103
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com